Dr. Barry Dworkin

Observational study noted that patients with diabetes and obesity using GLP-1 medications may experience reduced degree of metastases. Causality confirmation and mechanisms to be determined.

Medical Mythbusting Commentary for May 25, 2026

Source:
GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss

Related posts:

  1. Genes research offers cancer treatment hope
  2. Study demonstrates new diagnostic method to predict survival/relapse outcomes in classic Hodgkin's Lymphoma
  3. Proof of concept that dichloroacetate inhibits cancer cell growth: more studies to follow
  4. No link established between blood pressure medications (ARBs) and cancer